Department of Neurology, Inserm, U1172-LilNCog-Lille Neuroscience & Cognition, CHU-Lille, Univ. Lille, F-59000, Lille, France.
Neurology and Stroke Unit, Luigi Sacco Hospital, Milan, Italy.
Neurol Sci. 2024 May;45(5):2127-2135. doi: 10.1007/s10072-023-07196-8. Epub 2023 Nov 23.
Fatigue is a major complaint in stroke survivors, but data focusing on intracerebral haemorrhage (ICH) survivors are scarce. In a cohort of spontaneous ICH survivors, we assessed the long-term prevalence of fatigue and its associated factors.
We included consecutive 1-year ICH survivors from the prospective, observational, single-centre Prognosis of Intracerebral Haemorrhage (PITCH) study. We evaluated fatigue (defined as a score ≥ 4 in Chalder Fatigue Scale); the severity of neurological, depressive, and anxiety symptoms; and functional disability 1, 3, and 6 years after ICH. We performed univariable and multivariable models to evaluate clinical factors and brain magnetic resonance imaging (MRI) small vessel disease (SVD) markers associated with fatigue.
Of 255 1-year ICH survivors, 153 (60%) underwent fatigue screening and were included in this study. Seventy-eight patients (51%) reported fatigue at 1-year, 56/110 (51%) at 3-year, and 27/67 (40%) at 6-year follow-up. Patients with fatigue exhibited more severe concomitant depressive/anxiety symptoms, but the severity of depressive symptoms was the only clinical factor significantly associated with 1-year fatigue in multivariable analysis (adjusted odds ratio 1.4 for one-point increase; 95% confidence interval 1.2-1.6). Patients with severe cortical atrophy at baseline had increased risk of fatigue at 1-year follow-up compared to patients with mild/no cortical atrophy (adjusted odds ratio 2.5; 95% confidence interval 1.1-5.8).
Fatigue after ICH is frequent and long-lasting, and it is associated with cortical atrophy (but not with other MRI markers of cerebral SVD). The link between fatigue and depressive symptoms may represent a potential therapeutic target.
疲劳是脑卒中幸存者的主要抱怨,但针对颅内出血(ICH)幸存者的数据却很少。在一项自发性ICH 幸存者队列中,我们评估了长期疲劳的发生率及其相关因素。
我们纳入了前瞻性、观察性、单中心 Prognosis of Intracerebral Haemorrhage(PITCH)研究中连续的 1 年 ICH 幸存者。我们评估了疲劳(定义为 Chalder 疲劳量表得分≥4);神经、抑郁和焦虑症状的严重程度;以及 ICH 后 1、3 和 6 年的功能障碍。我们进行了单变量和多变量模型,以评估与疲劳相关的临床因素和脑磁共振成像(MRI)小血管疾病(SVD)标志物。
在 255 名 1 年 ICH 幸存者中,有 153 名(60%)进行了疲劳筛查,并纳入本研究。78 名患者(51%)在 1 年时报告疲劳,110 名患者中的 56 名(51%)在 3 年时报告疲劳,67 名患者中的 27 名(40%)在 6 年时报告疲劳。患有疲劳的患者表现出更严重的伴发抑郁/焦虑症状,但在多变量分析中,抑郁症状的严重程度是唯一与 1 年疲劳显著相关的临床因素(调整后的优势比为每增加 1 分,1.2-1.6)。与轻度/无皮质萎缩的患者相比,基线时存在严重皮质萎缩的患者在 1 年随访时发生疲劳的风险增加(调整后的优势比为 2.5;95%置信区间为 1.1-5.8)。
ICH 后疲劳很常见且持续时间长,与皮质萎缩有关(但与脑 SVD 的其他 MRI 标志物无关)。疲劳与抑郁症状之间的联系可能代表一个潜在的治疗靶点。